A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice

Scandinavian Journal of Immunology

Volumn 61, Issue 3, 2005, Pages 266-273

  Cai, Y ^a   Tang, X D ^b   Zhou, P J ^c  

^a First Affil Hosp Wenzhou Med C   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MONOCLONAL ANTIBODY; RAPAMYCIN; T LYMPHOCYTE RECEPTOR; TACROLIMUS;

ADOPTIVE TRANSFER; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; CYTOARCHITECTURE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEART GRAFT; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECIPIENT; SURVIVAL TIME;

ADOPTIVE TRANSFER; ANIMALS; CLONAL ANERGY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; ISOANTIGENS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; SIROLIMUS; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION, HOMOLOGOUS;

EID: 16244398865     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2005.01555.x     Document Type: Article

References (26)

1. Yan J, Ma B, Guo X et al. CD 80(B7-1) expression on human tumor cell lines and its costimulatory signals for T cell proliferation and cytokine production. Chin Med J (Engl) 1998;111:269-71.
2. Vierboom MP, Ossevoort M, Sick EA et al. Induction of allograft tolerance through costimulatory blockade: first selection of drugs in vitro. Transpl Immunol 2003;11:215-22.
3. Vendetti S, Chai JG, Dyson J et al. Anergic T cells inhibit the antigen-presenting function of dendritic cells. J Immunol 2000;165:1175-81.
4. Luo Z, Gotoh M, Grochowiecki T et al. Anergic T cells generated in vitro suppress rejection response to islet allografts. Transplantation 2000;69:2144-8.
5. Zhang Y, Lorre K, Boer M et al. B7-blockin agents, alone or in combination with cyclosporin A, induce antigen-specific anergy of human memory I cells. J Immunol 1997;158:4734-40.
6. Koenen HJ, Joosten I. Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness. Blood 2000;95:3153-61.
7. Kahan BD, Camardo JS. Rapamycin: clinical results and future opportunities. Transplantation 2001;72:1181-93.
8. Demirci G, Strom TB, Li XC. New approacher in tolerance induction. Curr Opin Organ Transplant 2001;6:89-94.
9. Hancock WW, Sayegh MH, Zheng XG et al. Costimulatory function and expression of CD40 ligand, CD80 and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 1996;93:13967-72.
10. Tivol EA, Boyd SD, McKeon S et al. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J Immunol 1997;158:5091-4.
11. Larsen CP, Pearson TC. The CD40 pathway in allograft rejection, acceptance, and tolerance. Curr Opin Immunol 1997;9:641-7.
12. Cobbold S, Waldmann H. Infectious tolerance. Curr Opin Immunol 1998;10:518-24.
13. Karim M, Bushell AR, Wood KJ. Regulatory T cells in transplantation. Curr Opin Immunol 2002;14:584-91.
14. Onodera K, Lehmann M, Akalin E et al. Induction of 'infectious' tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J Immunol 1996;157:1944-50.
15. Saitovitch D, Bushell A, Mabbs DW et al. Kinetics of induction of transplantation tolerance with a nondepleting anti-CD4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness. Transplantation 1996;61:1642-7.
16. Yamagiwa S, Gray JD, Hashimoto S et al. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol 2001;166:7282-9.
17. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002;99:3493-9.
18. Li Y, Li XC, Zheng XX et al. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 1999;5:1298-302.
19. Wolf M, Schimpl A, Hunig T. Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms. Eur J Immunol 2001;31:1637-45.
20. Gourishankar S, Turner P, Halloran P. New developments in immunosuppressive therapy in renal transplantation. Expert Opin Biol Ther 2002;2:483-501.
21. Calne R, Moffatt SD, Friend PJ et al. Campath 1H allows low-dose cyclosporine monotherapy in 31 cadaveric tenal allograft recipients. Transplantation 1999;68:1613-6.
22. Thomas JM, Contreras JL, Jiang XL et al. Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 1999;68:1660-73.
23. Calne R. 'Almost tolerance' in the clinic. Transplant Proc 1998;30:3846.
24. Ng WF, Hernandez-Fuentes M, Baker R et al. Reversibility with interleukin-2 suggests that T cell anergy contributes to donor-specific hyporesponsiveness in renal transplant patients. J Am Soc Nephrol 2002;13:2983-5.
25. VanBuskirk AM, Burlingham WJ, Jankowska-Gan E et al. Human allograft acceptance is associated with immune regulation. J Clin Invest 2001;106:145-6.
26. Chai JG, Bartok I, Chandler P et al. Anergic T cells act as suppressor cells in vitro and in vivo. Eur J Immunol 1999;29:686-92.